116 related articles for article (PubMed ID: 2422578)
1. [Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases. Basic study and clinical application].
Yoshida Y; Ueki S; Takahashi A; Takagi H; Torigoe H; Kudo S
Neurol Med Chir (Tokyo); 1985 Dec; 25(12):989-97. PubMed ID: 2422578
[No Abstract] [Full Text] [Related]
2. [Postoperative intrathecal irrigation with plasminogen activator (Urokinase) after early stage operation on ruptured cerebral aneurysm].
Yoshida Y; Hayashi T; Amoh M; Ahagon A; Kusuno K; Uno T; Ogino T; Kobayashi H; Shibata N; Ueki S
Neurol Med Chir (Tokyo); 1983 Aug; 23(8):659-66. PubMed ID: 6197673
[No Abstract] [Full Text] [Related]
3. Vasospasm prevention with postoperative intrathecal thrombolytic therapy: a retrospective comparison of urokinase, tissue plasminogen activator, and cisternal drainage alone.
Usui M; Saito N; Hoya K; Todo T
Neurosurgery; 1994 Feb; 34(2):235-44; discussion 244-5. PubMed ID: 8177383
[TBL] [Abstract][Full Text] [Related]
4. Indications for cisternal irrigation with urokinase in postoperative patients with aneurysmal subarachnoid haemorrhage.
Hirashima Y; Endo S; Horie Y; Kurimoto M
Br J Neurosurg; 1996 Oct; 10(5):477-81. PubMed ID: 8922707
[TBL] [Abstract][Full Text] [Related]
5. Prevention of vasospasm by clot removal and intrathecal bolus injection of tissue-type plasminogen activator: preliminary report.
Mizoi K; Yoshimoto T; Fujiwara S; Sugawara T; Takahashi A; Koshu K
Neurosurgery; 1991 Jun; 28(6):807-12; discussion 812-3. PubMed ID: 1906142
[TBL] [Abstract][Full Text] [Related]
6. Prevention of delayed ischaemic deficits after aneurysmal subarachnoid haemorrhage by intrathecal bolus injection of tissue plasminogen activator (rTPA). A prospective study.
Seifert V; Stolke D; Zimmermann M; Feldges A
Acta Neurochir (Wien); 1994; 128(1-4):137-43. PubMed ID: 7847131
[TBL] [Abstract][Full Text] [Related]
7. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage.
Sasaki T; Ohta T; Kikuchi H; Takakura K; Usui M; Ohnishi H; Kondo A; Tanabe H; Nakamura J; Yamada K
Neurosurgery; 1994 Oct; 35(4):597-604; discussion 604-5. PubMed ID: 7808602
[TBL] [Abstract][Full Text] [Related]
8. Combined cisternal drainage and intrathecal urokinase injection therapy for prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage.
Moriyama E; Matsumoto Y; Meguro T; Kawada S; Mandai S; Gohda Y; Sakurai M
Neurol Med Chir (Tokyo); 1995 Oct; 35(10):732-6. PubMed ID: 8532128
[TBL] [Abstract][Full Text] [Related]
9. [Preventive effect of intracisternal methylprednisolone on symptomatic vasospasm after aneurysmal subarachnoid hemorrhage].
Ohkuma H; Suzuki S; Ogane K; Fujita S; Shibata S; Ito K; Kimura M
No Shinkei Geka; 1996 Feb; 24(2):135-42. PubMed ID: 8849473
[TBL] [Abstract][Full Text] [Related]
10. [Cisternal irrigation therapy with urokinase for preventing vasospasm].
Sasaki T; Kodama N; Yamanobe K; Sakuma J
Nihon Rinsho; 1993 Dec; 51 Suppl():397-403. PubMed ID: 8121019
[No Abstract] [Full Text] [Related]
11. Effectiveness of the head-shaking method combined with cisternal irrigation with urokinase in preventing cerebral vasospasm after subarachnoid hemorrhage.
Kawamoto S; Tsutsumi K; Yoshikawa G; Shinozaki MH; Yako K; Nagata K; Ueki K
J Neurosurg; 2004 Feb; 100(2):236-43. PubMed ID: 15086230
[TBL] [Abstract][Full Text] [Related]
12. [An experimental study on intrathecal injection of fibrinolytic agent for angiospasm following subarachnoid hemorrhage in the dogs (author's transl)].
Yoshida Y; Handa H; Hayashi T; Amo M; Aoki M; Kusuno K; Lee E; Uno T
Nihon Geka Hokan; 1979 Mar; 48(2):188-96. PubMed ID: 162263
[No Abstract] [Full Text] [Related]
13. Effect on cerebral vasospasm of coil embolization followed by microcatheter intrathecal urokinase infusion into the cisterna magna: a prospective randomized study.
Hamada J; Kai Y; Morioka M; Yano S; Mizuno T; Hirano T; Kazekawa K; Ushio Y
Stroke; 2003 Nov; 34(11):2549-54. PubMed ID: 14563967
[TBL] [Abstract][Full Text] [Related]
14. [Preliminary clinical trial of intrathecal rt-PA (TD-2061) for the prevention of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage].
Sasaki T; Ohta T; Kikuch H; Takakura K; Usui M; Kondoh A; Tanabe H; Nakamura J; Yamada K
No To Shinkei; 1992 Nov; 44(11):1001-8. PubMed ID: 1296711
[TBL] [Abstract][Full Text] [Related]
15. [Intraoperative radical clot removal therapy using a bipolar irrigation system for prevention of cerebral vasospasm following subarachnoid hemorrhage].
Tsuruno T
No Shinkei Geka; 2005 Apr; 33(4):343-8. PubMed ID: 15830540
[TBL] [Abstract][Full Text] [Related]
16. Comparison of intrathecally administered urokinase, tissue-type plasminogen activator, and combination of urokinase and lysine-plasminogen for clot lysis after experimental subarachnoid hemorrhage in dogs.
Kajimoto Y; Ohta T; Kuroiwa T
Neurosurgery; 1997 Mar; 40(3):572-7. PubMed ID: 9055298
[TBL] [Abstract][Full Text] [Related]
17. Prognosis in ruptured cerebral aneurysms with early operation and nimodipine prophylaxis.
Auer LM
Minerva Med; 1986 Jun; 77(24):1103-10. PubMed ID: 3725136
[No Abstract] [Full Text] [Related]
18. Comparison of intrathecal administration of urokinase and tissue plasminogen activator on subarachnoid clot and chronic vasospasm in a primate model.
Hariton GB; Findlay JM; Weir BK; Kasuya H; Grace MG; Mielke BW
Neurosurgery; 1993 Oct; 33(4):691-6; discussion 696-7. PubMed ID: 8232810
[TBL] [Abstract][Full Text] [Related]
19. Cisternal irrigation with UK to prevent vasospasm.
Kodama N
Surg Neurol; 2000 Jul; 54(1):95. PubMed ID: 11203123
[No Abstract] [Full Text] [Related]
20. Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarachnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study.
Stolke D; Seifert V
Neurosurgery; 1992 Jun; 30(6):877-81. PubMed ID: 1614590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
